AI assistant
Korian — Earnings Release 2021
Feb 23, 2022
1465_iss_2022-02-23_41ec9888-f1f9-434b-8a29-99197cc4b090.pdf
Earnings Release
Open in viewerOpens in your device viewer

Annual Results 2021
Korian places its ESG commitments at the heart of its strategy and furthers its transformation to be a European, Mission-led company
Paris, 23rd February 2022 – Korian, the leading European care and support services group for the elderly and fragile, announces its Q4 revenue and its 2021 results.
Sophie Boissard, CEO of Korian Group:
"Following two years fighting the Covid-19 pandemic and whilst the nursing home model comes under scrutiny in France, the Korian community has remained more than ever committed to providing high quality care and support to the elderly and fragile in our society, through its three activities, long term elderly care, post-acute healthcare and community care.
I would like to pay tribute to the unwavering commitment and professionalism of the Korian teams across Europe, that has enabled us to progress significantly in our environmental and social objectives, particularly focused on employment and qualifying training.
I would like to thank all our stakeholders, and in particular our residents, patients, clients and their families for their trust and the quality of our dialogue in all of the communities where we are present. We are determined to build with our stakeholders the solutions and the infrastructure to accompany and care for the elderly and vulnerable with dignity. Thus contributing to solving the societal challenges posed by ageing and chronic diseases across Europe. It's with this aim in mind that we are starting our transformation to become a European, Mission-led company."
***
▪ Committed to quality of care and quality of work
- 240 facilities certified ISO 9001 (29% of network versus 11% in 2020),
- Net Promoter Score from family, residents and patients of 34, well above the average of BtoC services sector of 231
- 5,302 employees involved in a qualifying education programme: 9.7% of the Group's staff compared to 8% in 2020 and close to target of 10% for 2023
- Average tenure of staff 7.4 years (up 0.5 year on 2020)
- Pioneering Health and Safety at Work for the sector: Agreement signed by trade unions in France and a European Health & Safety Protocole with the European Works Council
▪ Strengthening the sustainable business model through significant investment
- Investment in employees:
- o Increase in the percentage of revenue spent on staff (59% in 2021 versus 52% in 2016)
- o Launch of first European Employee Shareholding Ownership Plan
- Investment in the network: €409m invested to improve and extend services
- Acceleration of outpatient and homecare: +50% outpatient care capacity and +20% in residential care (200 co-living and assisted living facilities)
▪ Performance in line with objectives
- Revenue of € 4,311 million: +11.3% growth of which +5.9% organic, reflecting activity normalisation
- EBITDA (pre IFRS16) of € 597.2 million with a margin rate of 13.9%
- Net profit at €117.3 million, 2.7% of revenue, remaining down compared to 2019
- FCF prior to investment of € 230 million
- Net income Group share € 94.6 €million or 2.2% of revenue
▪ Solid balance sheet and reinforced liquidity
- Stable operational leverage at 3.1x
- Real Estate portfolio valued at € 3.2 billion with a stable Loan to Value of 55%
- Average maturity of the net debt extended to c.6 years and reduction of average cost to 2%
- Liquidity of € 1.7 billion
▪ 2022 financial guidance
- Continued growth momentum in all three segments with an organic contribution above 4%
- Continued normalization of EBITDA margin and FCF
▪ Next steps for the governance: transformation into a European company and the launch of the transformation to be a Mission Led company
- Publication of the resolutions to the AGM on 18th May 2022
- AGM to be convened on 22th June 2022
1 European survey carried out by IPSOS with 52,368 respondants (Nursing Homes, Assisted Living and clinics)

FINANCIAL INFORMATION
The consolidated financial statements for 2021 were approved by the Board of Directors at its meeting of 23th February 2022.
The Statutory Auditors are In the process of issuing a report with an unqualified opinion. The consolidated financial statements were prepared in accordance with the IFRS 16 standard. For purposes of comparability, the financial information below is presented excluding the application of IFRS 16.

Group Income Statement
| €M | FY 2021 Incl. IFRS 16 |
IFRS 16 adjustments |
2 FY 2021 Excl. IFRS 16 |
FY 2020 Excl. IFRS 16 |
FY 2019 Excl. IFRS 16 |
|---|---|---|---|---|---|
| Revenue | 4 310,8 | - | 4 310,8 | 3 874,0 | 3 612,5 |
| Staff costs | (2 532,8) | - | (2 532,8) | (2 243,9) | (2 005,3) |
| % of revenue | 58,8% | - | 58,8% | 57,9% | 55,5% |
| Other costs | (704,5) | 7,9 | (696,6) | (681,9) | (659,1) |
| % of revenue | 16,3% | - | 16,2% | 17,6% | 18,2% |
| EBITDAR | 1 073,6 | 7,9 | 1 081,5 | 948,3 | 948,1 |
| % of revenue | 24,9% | - | 25,1% | 24,5% | 26,2% |
| External rents | (63,8) | (420,6) | (484,4) | (450,0) | (413,0) |
| % of revenue | 1,5% | - | 11,2% | 11,6% | 11,4% |
| EBITDA | 1 009,8 | (412,7) | 597,2 | 498,2 | 535,1 |
| % of revenue | 23,4% | - | 13,9% | 12,9% | 14,8% |
| Amortisation & Depreciations | (602,6) | 371,9 | (230,7) | (201,6) | (178,3) |
| Provisions | (23,7) | - | (23,7) | (25,3) | (19,1) |
| EBIT | 383,6 | (40,8) | 342,8 | 271,3 | 337,7 |
| % of revenue | 8,9% | - | 8,0% | 7,0% | 9,3% |
| Non current expenses | (41,7) | - | (41,7) | (38,5) | (15,7) |
| Operating income | 341,9 | (40,8) | 301,1 | 232,8 | 322,1 |
| % of revenue | 7,9% | - | 7,0% | 6,0% | 8,9% |
| Financial result | (210,0) | 70,0 | (140,0) | (138,7) | (119,9) |
| Net income before tax | 131,9 | 29,2 | 161,1 | 94,1 | 202,2 |
| Income tax | (13,5) | (6,5) | (20,0) | (25,8) | (64,7) |
| Tax rate | 10,2% | 22,3% | 12,4% | 27,4% | 32,0% |
| Income from equity method | (2,0) | (2,0) | (0,8) | - | |
| Minority Interests | (21,8) | - | (21,8) | (2,7) | (1,5) |
| Net profit - Group share | 94,6 | 22,7 | 117,3 | 64,9 | 136,0 |
| % of revenue | 2,2% | - | 2,7% | 1,7% | 3,8% |

Balance Sheet
| in M€ | 31.12.2021 | 31.12.2020 |
|---|---|---|
| Goodwill | 3 214 | 2 906 |
| Intangible assets | 2 191 | 2 158 |
| Property, plant and equipment | 3 078 | 2 645 |
| Rights of use | 3 469 | 3 457 |
| Financial assets | 43 | 65 |
| Equity-accounted investments | 19 | 5 |
| Deferred tax assets | 95 | 79 |
| Non-current assets | 12 110 | 11 315 |
| Inventories | 28 | 36 |
| Trade receivables and related accounts | 365 | 315 |
| Other receivables and currents assets | 453 | 336 |
| Current tax receivables | 60 | 34 |
| Financial instruments – assets | 7 | 2 |
| Cash and cash equivalents | 1 215 | 1 159 |
| Current assets | 2 128 | 1 883 |
| Assets held for sale | 77 | |
| TOTAL ASSETS | 14 315 6 |
13 197 |
| In M€ | 31.12.2021 | 31.12.2020 |
|---|---|---|
| Share capital | 528 | 525 |
| Premiums | 1 196 | 1 183 |
| Reserves and consolidated results | 1 776 | 1 449 |
| Equity attributable to owners of the Group | 3 500 | 3 157 |
| Non-controlling interests | 271 | 166 |
| Total shareholder's equity | 3 771 | 3 323 |
| Provisions for pensions | 99 | 100 |
| Deferred tax liabilities | 584 | 605 |
| Other provisions | 50 | 62 |
| Loans and financial liabilities | 3 761 | 3 047 |
| Non-current lease liabilities | 3 425 | 3 351 |
| Other non-current liabilities | 173 | 96 |
| Non-current liabilities | 8 093 | 7 261 |
| Provisions for current liabilities | 16 | 10 |
| Trade payables and related accounts | 500 | 454 |
| Other payables and accruals | 761 | 770 |
| Dettes d'impôt courant | 69 | 29 |
| Borrowings due within one year and bank overdrafts | 681 | 952 |
| Current lease liabilities | 360 | 362 |
| Financial instruments - Liabilities | 21 | 38 |
| Current liabilities | 2 407 | 2 614 |
| Liabilities held for sale | 44 | |
| TOTAL LIABILITIES | 14 315 | 13 197 |

Group Cash Flow Statement
| €M | FY 2021 Incl. IFRS 16 |
IFRS 16 impact | FY 2021 Excl. IFRS 16 |
FY 2020 Excl. IFRS 16 |
|---|---|---|---|---|
| EBITDA | 1 009,9 | 412,7 | 597,2 | 498,2 |
| Non cash & others Change in WCR Operating Capex |
0,2 (94,0) (91,3) |
20,3 0,4 - |
(20,0) (94,3) (91,3) |
(22,8) 11,7 (86,9) |
| Operating cash flow | 824,8 | 433,3 | 391,4 | 400,2 |
| Income taxes paid | (39,4) | - | (39,4) | (62,8) |
| Financial expenses paid/received | (192,3) | (69,8) | (122,5) | (114,4) |
| Operating free cash flow | 593,1 | 363,5 | 229,6 | 223,0 |
| Development Capex | (188,9) | - | (188,9) | (111,7) |
| Financial investments (bolt-on acquisitions) | (220,3) | - | (220,3) | (530,0) |
| Net free cash flow | 183,8 | 363,5 | (179,7) | (418,7) |
| Dividends paid | (36,4) | - | (36,4) | (10,2) |
| Real estate investments / divestments | (473,5) | - | (473,5) | (591,2) |
| Cash from Real Estate equity partnerships & other | (135,1) | (485,7) | 350,6 | 662,4 |
| Change in total net debt | (461,2) | (122,1) | (339,1) | (357,6) |

NON-FINANCIAL INFORMATION
15 ESG Commitment – 2021 Achievements
| PROVIDE CARE EXCELLENCE WHILST |
Positive Care | ISO 9001 certification | Chartered Mediator | |||||
|---|---|---|---|---|---|---|---|---|
| ENSURING DIGNITY AND CHOICE |
80% | A | 29% | A | ()은 한() | |||
| BE THE EMPLOYER | Average Tenure | Qualifying training programme | Women in Top Management | |||||
| / | OF CHOICE | N | 7.4y | A | 9.7% | → | 47% | |
| 3 | CONTRIBUTE TO FINDING INNOVATIVE SOLUTIONS FOR MORE INCLUSIVE SOCIETY |
Philanthropic actions | Stakeholder Councils | Scientific publications | ||||
| S | 1.6% RNPG | 1 | () = () = | ு | 40 | |||
| BE A COMMITTED AND RESPONSIBLE |
Local purchasing | Community projects | Local community & family Councils |
|||||
| 4 | LOCAL PARTNER | (~) | 78% / SME 36% | (2 | 99% | A | 89% | |
| REDUCE OUR ENVIRONMENTAL FOOTPRINT |
CO2 Ongoing |
Residual waste | Energy efficient buildings | |||||
| Ongoing | 95% | |||||||
| -40% CARRON REDITCTION RY 2030 |

About Korian
Korian, the leading European care services group for elderly and fragile people. www.korian.com
Korian has been listed on Euronext Paris Section A since November 2006 and is included in the following indices: SBF 120, CAC Health Care, CAC Mid 60, CAC Mid & Small and MSCI Global Small Cap
Euronext ticker: KORI - ISIN: FR0010386334 – Reuters: KORI.PA – Bloomberg: KORI.FP
INVESTOR RELATIONS
Sarah Mingham VP Investor Relations & Financing [email protected] Tel: +33 (0)1 55 37 53 55
Carole Alexandre Deputy Head of Investor Relations [email protected] Tel: +33 (0)7 64 65 22 44
MEDIA CONTACTS
Cyrille Lachevre
[email protected] Tél. : 06 20 42 12 08
Pascal Jentsch VP International communications [email protected] Tél. 07 65 18 58 55
Marjorie Castoriadis Head of Media Relations [email protected] Tel: +33 (0)7 63 59 88 81